• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

    29.70 -6.04 (-16.89%)
    Streaming Delayed Price Updated: 3:07 PM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,583,562
    Open 31.68
    Bid (Size) 29.63 (500)
    Ask (Size) 29.75 (200)
    Prev. Close 35.74
    Today's Range 28.90 - 33.03
    52wk Range 29.70 - 50.79
    Shares Outstanding 32,250,236
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Collegium Pharmaceutical Q2 Earnings Call Highlights ↗
    Collegium Pharmaceutical (NASDAQ:COLL) reported second-quarter 2026 net product revenue of $199.9 million, up 6% from a year earlier, as growth in its ADHD franchise and BELBUCA helped offset lower... 
    Via MarketBeat
    Topics Earnings
    Collegium Pharmaceutical (NASDAQ:COLL) Tumbles on Revenue Miss and Lowered Guidance ↗
    Via Chartmill

    Performance

    YTD
    -34.8%
    -34.8%
    1 Month
    -20.7%
    -20.7%
    3 Month
    -18.6%
    -18.6%
    6 Month
    -38.3%
    -38.3%
    1 Year
    -4.5%
    -4.5%

    More News

    Read More
    News headline image
    Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops
    Via StockStory
    News headline image
    Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect
    Via StockStory
    Collegium Pharmaceutical (NASDAQ:COLL) Surges on Q1 Earnings Beat as JORNAY PM Revenue Jumps 36% ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    1 Healthcare Stock with Competitive Advantages and 2 We Question
    Via StockStory
    News headline image
    1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
    Via StockStory
    News headline image
    1 Mooning Stock to Own for Decades and 2 That Underwhelm
    Via StockStory
    News headline image
    2 Profitable Stocks to Keep an Eye On and 1 We Brush Off
    Via StockStory
    News headline image
    3 of Wall Street’s Favorite Stocks We Approach with Caution
    Via StockStory
    News headline image
    Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    2 Reasons to Sell COLL and 1 Stock to Buy Instead
    Via StockStory
    Topics Supply Chain
    News headline image
    Collegium to Participate in 2026 Jefferies Global Healthcare Conference
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    3 Growth Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
    Via StockStory
    Topics Earnings
    News headline image
    Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
    Via StockStory
    News headline image
    COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results
    Via StockStory
    News headline image
    Collegium (COLL) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars
    Via StockStory

    Frequently Asked Questions

    Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
    Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
    What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
    Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
    The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
    What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
    The current price of Collegium Pharmaceutical, Inc. - Common Stock is 29.70
    When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
    The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 08/06/26 03:07 PM ET
    What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
    The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 957.99M
    How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
    Collegium Pharmaceutical, Inc. - Common Stock has 958M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.